Molecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions
March 10, 2022
December 15, 2021
December 6, 2021
March 20, 2023
Doctors in the U.S. can now access a novel NAD blood diagnostic for their patients. This is thanks to the launch of a new partnership with epigenetic ...
March 7, 2023
NDA Group is thrilled to announce the expansion of their Advisory Board with the appointment of Marianne Scheel Fjording, Ph.D. Marianne is a highly e...
March 6, 2023
New insight into drug mechanisms and disease progression can now be uncovered for more efficacious therapy development TransCure bioServices has devel...